# The Natural History of Wounds in Patients With Dystrophic Epidermolysis Bullosa (DEB)

> **NCT04214002** · — · WITHDRAWN · sponsor: **Krystal Biotech, Inc.**

## Conditions studied

- Dystrophic Epidermolysis Bullosa
- DEB - Dystrophic Epidermolysis Bullosa

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04214002
- **Lead sponsor:** Krystal Biotech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-01
- **Primary completion:** 2020-02-24
- **Final completion:** 2020-02-24
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to the COVID-19 Pandemic, the study was withdrawn.
- **Last updated:** 2021-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04214002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04214002, "The Natural History of Wounds in Patients With Dystrophic Epidermolysis Bullosa (DEB)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04214002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*